Hemex Health, Inc. is a medical diagnostics company focused on portable, point-of-care testing for blood disorders and certain infectious diseases. The company is known for its Gazelle platform, which identifies and quantifies hemoglobin variants to support screening and management of conditions such as sickle cell disease and thalassemia. Its solutions are designed to deliver rapid results near the patient, helping expand access to testing in both clinical and resource-limited settings.
Hemex Health works with healthcare providers, laboratories, researchers, and public health programs to enable earlier diagnosis and ongoing monitoring of disease. By combining compact instrumentation with disposable tests and digital data capabilities, the company aims to support scalable, standardized diagnostics in community and clinical environments.